EGRX - Eagle Pharmaceuticals Inc
IEX Last Trade
5.13
-0.110 -2.144%
Share volume: 53,661
Last Updated: Fri 30 Aug 2024 09:59:52 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$5.24
-0.11
-2.10%
Summary score
26%
Profitability
29%
Dept financing
11%
Liquidity
31%
Performance
25%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2019 - 30-Jun-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
1.39%
Return on assets
2.7%
Return on sales
11.75%
Return on invested capital
-17.1%
Total debt ratio
33.71%
Debt ratio change over timeo
-4.13%
Current Ratio
3%
Quick Ratio
2.72%
Cash Position Ratio
1.54%
Short-term ratios 30-Jun-2022 - 30-Jun-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
1.21%
Return on assets
2.54%
Return on sales
15.91%
Return on invested capital
1.83%
Total debt ratio
40.41%
Debt ratio change over timeo
3.89%
Current Ratio
1.84%
Quick Ratio
1.36%
Cash Position Ratio
0.26%
Last quarter ratios 30-Jun-2023
The data are presented for the financials results of the last quarter.
Return on equity
2.05%
Return on assets
2.55%
Return on sales
15.94%
Return on invested capital
3.94%
Total debt ratio
37.74%
Debt ratio change over time
8.57%
Current Ratio
2.16%
Quick Ratio
1.67%
Cash Position Ratio
0.18%
Performance ratios (change over 4 years) 30-Jun-2019 - 30-Jun-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-166.42%
Return on assets
-187.98%
Return on sales
-537.32%
Return on invested capital
-483.39%
Total debt ratio
-413.04%
Debt ratio change over time
-4.13%
Current Ratio
-63.97%
Quick Ratio
-62.01%
Cash Position Ratio
-39.24%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | EGRX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 1.39% | 5.24% | 35.86% | 7.9% |
| Return on assets | 2.7% | 3.12% | 3.56% | 5.95% |
| Return on sales | 11.75% | 31.5% | 36.15% | 41.33% |
| Return on invested capital | -17.1% | 4.08% | 6.32% | 20.63% |
| Profitability | 19% | 41% | 69% | 81% |
| Total debt ratio | 33.71% | 93.78% | 88.68% | 27.19% |
| Debt ratio change over time | -4.13% | 291.08% | 15.01% | 0.97% |
| Dept financing | 9% | 50% | 25% | 7% |
| Current Ratio | 1.84% | 0.94% | 2.25% | 5.33% |
| Quick Ratio | 1.36% | 0.82% | 1.93% | 4.53% |
| Cash Position Ratio | 0.26% | 0.3% | 1.4% | 2.67% |
| Liquididy | 59% | 23% | 35% | 75% |
| Short-term ratios | EGRX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 1.21% | 14.06% | 44.07% | 4.73% |
| Return on assets | 2.54% | 3.29% | 3.18% | 3.77% |
| Return on sales | 15.91% | 32% | 34.58% | 34.56% |
| Return on invested capital | 1.83% | 2.77% | 7.32% | 10.76% |
| Profitability | 33% | 59% | 88% | 78% |
| Total debt ratio | 40.41% | 89.22% | 93.78% | 22.11% |
| Debt ratio change over time | 3.89% | 98.45% | 12.55% | 1.14% |
| Dept financing | 12% | 49% | 28% | 6% |
| Current Ratio | 1.84% | 0.94% | 2.25% | 5.33% |
| Quick Ratio | 1.36% | 0.82% | 1.93% | 4.53% |
| Cash Position Ratio | 0.26% | 0.3% | 1.4% | 2.67% |
| Liquididy | 19% | 12% | 34% | 75% |